ITGAX and neoplasm: To obtain global information on DC changes after tumour inoculation at different times of the day, we performed RNA-sequencing (RNA-seq) analyses of the subset of CD11c+MHCIIhigh migratory DCs in the dLN collected 24 h after tumour engraftment or sham conditions, inoculated at ZT3, ZT9, ZT15 or ZT21.